Valuation: Photocure ASA

Market Cap 1.38B 147M 127M 120M 109M 205M 14.11B 206M 1.44B 556M 7.16B 552M 540M 22.81B P/E 2026 *
18.1x
P/E 2027 * 65.5x
Enterprise Value 1.21B 129M 112M 106M 95.93M 180M 12.38B 181M 1.26B 487M 6.28B 485M 474M 20.01B EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.83x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.98%
1 week-3.19%
Current month-5.32%
1 month-10.26%
3 months-15.69%
6 months-23.33%
Current year-27.73%
1 week 50.6
Extreme 50.6
53.6
1 month 50.6
Extreme 50.6
60.5
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 41.7
Extreme 41.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
2/4/25 BuyCompany 11,355 0.0419%
2/4/25 BuyCompany 8,997 0.0332%
31/3/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%-3.19%-12.84%+21.27% 147M
-0.11%+1.43%+49.11%+99.59% 1,013B
+0.20%+0.44%+52.02%+65.11% 644B
-0.34%+4.85%+21.65%+70.90% 465B
+0.53%+4.26%+40.29%+40.53% 352B
+0.39%+2.35%+17.96%+24.19% 264B
+0.17%+4.17%+6.96%+13.12% 253B
+0.06%-3.49%+38.28%+43.50% 203B
-1.20%-5.64%-24.09%-58.09% 188B
+0.67%+1.78%+33.72%+96.04% 181B
Average +0.12%-1.35%+22.31%+41.62% 356.38B
Weighted average by Cap. -0.02%+0.01%+34.60%+60.33%

Financials

2026 *2027 *
Net sales 658M 70.4M 61.01M 57.66M 52.35M 98.11M 6.75B 98.7M 688M 266M 3.43B 264M 259M 10.92B 666M 71.25M 61.75M 58.36M 52.98M 99.3M 6.84B 99.9M 697M 269M 3.47B 268M 262M 11.05B
Net income 76.33M 8.16M 7.07M 6.69M 6.07M 11.38M 783M 11.44M 79.81M 30.84M 397M 30.66M 29.98M 1.27B 21M 2.25M 1.95M 1.84M 1.67M 3.13M 215M 3.15M 21.96M 8.48M 109M 8.44M 8.25M 348M
Net Debt -169M -18.07M -15.66M -14.8M -13.44M -25.19M -1.73B -25.34M -177M -68.28M -879M -67.89M -66.38M -2.8B -157M -16.79M -14.55M -13.75M -12.48M -23.4M -1.61B -23.54M -164M -63.43M -817M -63.07M -61.67M -2.6B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
17/09/26 NOK 51.60 +0.98% 60,082
15/09/26 NOK 51.10 -0.78% 31,977
14/09/26 NOK 51.50 -0.77% 62,199
11/09/26 NOK 51.90 -2.44% 44,099
10/09/26 NOK 53.20 -0.19% 32,881
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
51.10NOK
Average target price
79.67NOK
Spread / Average Target
+55.90%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!